Evidence map›Paper›PMID 40365520›Full record

ArticleJournal of cardiovascular and thoracic research2025

Baseline characteristics and seven-year follow-up of patients with coronary slow flow: A cohort study in northeastern Iran.

Farima Farsi, Negar Morovatdar, Ali Eshraghi

Abstract read
In one paragraph

Article in Journal of cardiovascular and thoracic research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Comprehensive SNP-based evaluation of fat mass and obesity-associated geneJournal of diabetes and metabolic disorders · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Farima FarsiObesity and Eating Habits Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0003-3715-4858
Negar MorovatdarClinical Research Development Unit, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Ali EshraghiDepartment of Cardiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.ORCID https://orcid.org/0000-0002-3642-3553

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: An angiographic finding known as "coronary slow flow phenomenon" (CSFP) occurs when there is no discernible stenosis but the contrast flow is slower than usual. Although the prognosis for the majority of CSFP cases is favorable, frequent angina significantly lowers their quality of life. Therefore, this study aimed to explore the potential contributing risk factors and prognostic implications of CSFP on long-term cardiovascular outcomes. Methods: This retrospective, cohort study was conducted between years 2014-2022 and included a total of 65 CSFP patients and 65 controls with normal coronary flow, as evidenced by coronary angiography. These two groups were examined in terms of future cardiovascular consequences due to this phenomenon, baseline demographic characteristics, and laboratory findings. A Results: In this study 130 people including 73 men and 57 women, who because of the typical chest pain and at least a noninvasive test took angiography, were explored. The median triglyceride (200.80±48.51 vs 131.79±34.22, Conclusion: Our research indicated that individuals with CSFP were more likely to develop cardiac events including unstable angina. Furthermore, obesity and dyslipidemia could provoke this phenomenon.

Indexed as

Adverse cardiac eventsCoronary slow flowDyslipidemia

Identifiers

PMID40365520
PMCPMC12068793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.